| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 123I05210W |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Reticulon-4 inhibitor | PubMed |
| Primary Target | |
|---|---|
| reticulon 4 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Amyotrophic Lateral Sclerosis | 2 | D000690 | ClinicalTrials |
| Multiple Sclerosis | 1 | D009103 | ClinicalTrials |
| Multiple Sclerosis, Relapsing-Remitting | 1 | D020529 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1310680-64-8 |
| ChEMBL | CHEMBL2108679 |
| FDA SRS | 123I05210W |
| Guide to Pharmacology | 8254 |
CONTENTS